World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
23708
World Ranking
16668
National Ranking
8367

Lawrence N. Shulman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lawrence N. Shulman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 460 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lawrence N. Shulman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lawrence N. Shulman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1998 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Lawrence N. Shulman is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on medicine, with a significant portion dedicated to oncology. Over the course of their career, they have contributed to 310 publications in the field of medicine, including 135 specific to oncology.

Their subfields of study include economics and econometrics, public health, environmental and occupational health, pulmonary and respiratory medicine, and cancer research. This demonstrates a multidisciplinary approach linking economic factors, healthcare systems, and clinical oncology.

Frequent topics addressed in their work include:

  • Economic and Financial Impacts of Cancer
  • Global Cancer Incidence and Screening
  • COVID-19 and healthcare impacts
  • Palliative Care and End-of-Life Issues
  • Health Systems, Economic Evaluations, Quality of Life
  • Cancer survivorship and care
  • Advances in Oncology and Radiotherapy

Lawrence N. Shulman has published extensively in several prominent venues, including:

  • Journal of Clinical Oncology (35 publications)
  • JCO Global Oncology (21 publications)
  • JAMA Oncology (12 publications)
  • JCO Oncology Practice (11 publications)
  • JAMA Network Open (10 publications)

Their frequent coauthors consist of Peter Gabriel (42 papers), Justin E. Bekelman (34 papers), Ravi B. Parikh (29 papers), Cyprien Shyirambere (24 papers), and Lynn M. Schuchter (21 papers).

Selected recent papers by Lawrence N. Shulman include:

  • Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium, 2020, Breast Cancer Research and Treatment
  • Medical imaging and nuclear medicine: a Lancet Oncology Commission, 2021, The Lancet Oncology
  • Effect of Integrating Machine Learning Mortality Estimates With Behavioral Nudges to Clinicians on Serious Illness Conversations Among Patients With Cancer, 2020, JAMA Oncology
  • Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100,800 women from 86 randomised trials, 2023, The Lancet
  • Association of Medicaid Expansion Under the Affordable Care Act With Insurance Status, Cancer Stage, and Timely Treatment Among Patients With Breast, Colon, and Lung Cancer, 2020, JAMA Network Open

In recognition of their contributions, they were named a Fellow of the American Association for the Advancement of Science (AAAS) in 1998.

Best Publications

  • Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

    Sylvia Adams;Robert J. Gray;Sandra Demaria;Lori Goldstein

  • Expansion of cancer care and control in countries of low and middle income: a call to action.

    Paul Farmer;Julio Frenk;Felicia M Knaul;Lawrence N Shulman

  • Using the National Cancer Database for Outcomes Research: A Review.

    Daniel J. Boffa;Joshua E. Rosen;Katherine Mallin;Ashley Loomis

  • The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer.

    Recht A;Come Se;Henderson Ic;Gelman Rs

  • Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: Long-term results of Southwest Oncology Group trial 9416 (Intergroup trial 0160)

    Valerie W. Rusch;Dorothy J. Giroux;Michael J. Kraut;John Crowley

  • Clinical Activity of Trastuzumab and Vinorelbine in Women With HER2-Overexpressing Metastatic Breast Cancer

    Harold J. Burstein;Irene Kuter;Susana M. Campos;Rebecca S. Gelman

  • Prognostic Utility of the 21-Gene Assay in Hormone Receptor-Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

    Lori J. Goldstein;Robert Gray;Sunil Badve;Barrett H. Childs

  • Docetaxel Administered on a Weekly Basis for Metastatic Breast Cancer

    Harold J. Burstein;Judith Manola;Jerry Younger;Leroy M. Parker

  • Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated Daily

    Joseph P. Eder;Jeffrey G. Supko;Jeffrey W. Clark;Thomas A. Puchalski

  • Phase I Trial of Intraperitoneal Injection of the E1B-55-kd-Gene–Deleted Adenovirus ONYX-015 (dl1520) Given on Days 1 Through 5 Every 3 Weeks in Patients With Recurrent/Refractory Epithelial Ovarian Cancer

    P. A. Vasey;L. N. Shulman;S. Campos;J. Davis

  • Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.

    Jill R. Dietz;Meena S. Moran;Meena S. Moran;Steven J. Isakoff;Steven J. Isakoff;Scott H. Kurtzman

  • Association of sleep-disordered breathing with postoperative complications

    Dennis Hwang;Nawaid Shakir;Baba Limann;Cristina Sison

  • Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012-2014.

    Katherine Mallin;Amanda Browner;Bryan Palis

  • Breast Cancer in Developing Countries: Opportunities for Improved Survival

    Lawrence Nathan Shulman;Walter C. Willett;Amy Claire Sievers;Felicia Marie Knaul

  • Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer.

    A L Abner;A Recht;T Eberlein;S Come

  • Rwanda 20 years on: investing in life

    Agnes Binagwaho;Paul E. Farmer;Sabin Nsanzimana;Corine Karema

  • Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research, and Policy.

    Larissa Nekhlyudov;Michelle A Mollica;Paul B Jacobsen;Deborah K Mayer

  • Sequencing of Chemotherapy and Radiation Therapy in Early-Stage Breast Cancer: Updated Results of a Prospective Randomized Trial

    Jennifer R. Bellon;Steven E. Come;Rebecca S. Gelman;I. Craig Henderson

  • Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome

    PM Mauch;LA Kalish;KC Marcus;CN Coleman

  • Medication safety in the ambulatory chemotherapy setting.

    Tejal K. Gandhi;Sylvia B. Bartel;Lawrence N. Shulman;Deborah Verrier

Frequent Co-Authors

Nancy L. Keating
Nancy L. Keating Harvard University
Abram Recht
Abram Recht Beth Israel Deaconess Medical Center
Jay R. Harris
Jay R. Harris Brigham and Women's Hospital
Peter Mauch
Peter Mauch Brigham and Women's Hospital
Rebecca Gelman
Rebecca Gelman Harvard University
George P. Canellos
George P. Canellos Harvard University
Eric P. Winer
Eric P. Winer Yale University
Joseph A. Sparano
Joseph A. Sparano Albert Einstein College of Medicine
Nancy E. Davidson
Nancy E. Davidson University of Washington
Ann H. Partridge
Ann H. Partridge Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If studying Medicine in the USA feels overwhelming or not the right fit, consider related healthcare degrees and flexible learning options. Many students are turning to online programs for affordable, accessible, and career-focused education within the health sector.

For those interested in healthcare management and leadership, affordable mha online programs offer a pathway to roles in hospital administration, health policy, and more, without the high tuition costs.

Nursing professionals can enhance their qualifications through cheapest online dnp programs, opening doors to advanced practice, leadership, and academic positions.

Aspiring pharmacists might explore a pharmacy degree online, gaining critical knowledge and skills for pharmaceutical careers, often with more flexible and budget-friendly delivery.

Finally, technology-minded students may be drawn to a bachelor of health information management online. This route prepares graduates to work with patient data systems, healthcare IT, and informatics.

Each of these online healthcare degrees provides a unique entry into the medical field and reflects the growing accessibility of alternative career pathways in health sciences.

Best Scientists Citing Lawrence N. Shulman

Trending Scientists

Recently Published Articles